Atlas Trials

Safety and Dosage of a Computerized Cognitive Training Program for Cognitive Dysfunction After COVID-19

Clinical trial NCT05582603 · UNKNOWN

Trial details

NCT number
NCT05582603
Sponsor
Universidad Antonio de Nebrija
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Post-Acute COVID-19Post Acute COVID-19 SyndromeCognitive DysfunctionCognitive Impairment
Start date
2022-10-18
Primary completion
2022-11-30
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.